Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin

Xiaoping Huang, Li‐Zhi Gao, Shuiliang Wang, +5

Cancer Research

Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers

Xin‐Sheng Deng, Shuiliang Wang, Anlong Deng, +5

Cell Cycle

Breast OncologyImmunologyCell DeathCell GrowthStat3 Specific Inhibitor +17

Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation

Jin Chen, Junqiu Chen, Yuanhang Cheng, +10

Stem Cell Research & Therapy

CHOP favors endoplasmic reticulum stress-induced apoptosis in hepatocellular carcinoma cells via inhibition of autophagy

Lei Yan, Shuiliang Wang, Bingshuang Ren, +6

PLoS ONE

MitophagyApoptosisImmunologyHepatocellular Carcinoma CellsPathology +22

HDAC Inhibitor SNDX-275 Induces Apoptosis in erbB2-Overexpressing Breast Cancer Cells via Down-regulation of erbB3 Expression

Xiaoping Huang, Li‐Zhi Gao, Shuiliang Wang, +3

Cancer Research

Histone DeacetylasesBreast OncologyApoptosisCell DeathCancer Biology +15

The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells

Jingcao Huang, Shuiliang Wang, Hui Lyu, +4

Molecular Cancer

ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma

Jun Lü, Zhan Chen, Hu Zhao, +10

Journal of Translational Medicine

Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer

Shuiliang Wang, Jingcao Huang, Hui Lyu, +7

Breast Cancer Research

Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer

Hui Lyu, Shuiliang Wang, Jingcao Huang, +3

Cancer Letters

Mir-203 MimicTumor BiologyBreast OncologyHer2-overexpressing Breast CancerAntitumor Activity +13

MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF

Hu Zhao, Wei Zhang, Xiaofeng Lai, +6

Artificial Cells Nanomedicine and Biotechnology

Tumor BiologyUrologyMedicineProstate Cancer InhibitsCancer Biology +10